These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 26688323

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Omega-3 fatty acids predict recurrent venous thromboembolism or total mortality in elderly patients with acute venous thromboembolism.
    Reiner MF, Stivala S, Limacher A, Bonetti NR, Méan M, Egloff M, Rodondi N, Aujesky D, von Schacky C, Lüscher TF, Camici GG, Beer JH.
    J Thromb Haemost; 2017 Jan; 15(1):47-56. PubMed ID: 27790827
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A high Gas6 level in plasma predicts venous thromboembolism recurrence, major bleeding and mortality in the elderly: a prospective multicenter cohort study.
    Schnegg-Kaufmann A, Calzavarini S, Limacher A, Mean M, Righini M, Staub D, Beer JH, Frauchiger B, Osterwalder J, Kucher N, Matter CM, Husmann M, Banyai M, Aschwanden M, Mazzolai L, Hugli O, Nagler M, Daskalakis M, Rodondi N, Aujesky D, Angelillo-Scherrer A.
    J Thromb Haemost; 2019 Feb; 17(2):306-318. PubMed ID: 30570809
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis.
    Schulman S, Kakkar AK, Goldhaber SZ, Schellong S, Eriksson H, Mismetti P, Christiansen AV, Friedman J, Le Maulf F, Peter N, Kearon C, RE-COVER II Trial Investigators.
    Circulation; 2014 Feb 18; 129(7):764-72. PubMed ID: 24344086
    [Abstract] [Full Text] [Related]

  • 9. Dynamics of case-fatalilty rates of recurrent thromboembolism and major bleeding in patients treated for venous thromboembolism.
    Lecumberri R, Alfonso A, Jiménez D, Fernández Capitán C, Prandoni P, Wells PS, Vidal G, Barillari G, Monreal M, RIETE investigators.
    Thromb Haemost; 2013 Oct 18; 110(4):834-43. PubMed ID: 23846721
    [Abstract] [Full Text] [Related]

  • 10. Treatment with dabigatran or warfarin in patients with venous thromboembolism and cancer.
    Schulman S, Goldhaber SZ, Kearon C, Kakkar AK, Schellong S, Eriksson H, Hantel S, Feuring M, Kreuzer J.
    Thromb Haemost; 2015 Jul 18; 114(1):150-7. PubMed ID: 25739680
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Association between insurance status, anticoagulation quality, and clinical outcomes in patients with acute venous thromboembolism.
    Zumbrunn B, Stalder O, Méan M, Limacher A, Tritschler T, Rodondi N, Aujesky D.
    Thromb Res; 2019 Jan 18; 173():124-130. PubMed ID: 30529390
    [Abstract] [Full Text] [Related]

  • 14. Recurrence of venous thromboembolism among adults acute leukemia patients treated at the University of Texas MD Anderson Cancer Center: Incidence and risk factors.
    Luong NV, Kroll MH, Vu K.
    Thromb Res; 2017 Aug 18; 156():14-19. PubMed ID: 28577388
    [Abstract] [Full Text] [Related]

  • 15. Smoking and venous thromboembolism: a Danish follow-up study.
    Severinsen MT, Kristensen SR, Johnsen SP, Dethlefsen C, Tjønneland A, Overvad K.
    J Thromb Haemost; 2009 Aug 18; 7(8):1297-303. PubMed ID: 19566546
    [Abstract] [Full Text] [Related]

  • 16. Polypharmacy is associated with an increased risk of bleeding in elderly patients with venous thromboembolism.
    Leiss W, Méan M, Limacher A, Righini M, Jaeger K, Beer HJ, Osterwalder J, Frauchiger B, Matter CM, Kucher N, Angelillo-Scherrer A, Cornuz J, Banyai M, Lämmle B, Husmann M, Egloff M, Aschwanden M, Rodondi N, Aujesky D.
    J Gen Intern Med; 2015 Jan 18; 30(1):17-24. PubMed ID: 25143224
    [Abstract] [Full Text] [Related]

  • 17. Association of Traditional Cardiovascular Risk Factors With Venous Thromboembolism: An Individual Participant Data Meta-Analysis of Prospective Studies.
    Mahmoodi BK, Cushman M, Anne Næss I, Allison MA, Bos WJ, Brækkan SK, Cannegieter SC, Gansevoort RT, Gona PN, Hammerstrøm J, Hansen JB, Heckbert S, Holst AG, Lakoski SG, Lutsey PL, Manson JE, Martin LW, Matsushita K, Meijer K, Overvad K, Prescott E, Puurunen M, Rossouw JE, Sang Y, Severinsen MT, Ten Berg J, Folsom AR, Zakai NA.
    Circulation; 2017 Jan 03; 135(1):7-16. PubMed ID: 27831499
    [Abstract] [Full Text] [Related]

  • 18. Utility of a Nurse-Led Pathway for Patients with Acute Venous Thromboembolism Discharged on Rivaroxaban: A Prospective Cohort Study.
    Lim MS, Indran T, Cummins A, Bennett A, Wood E, Brown S, McQuilten Z, Tran H, Epi MC, Chan NC, Chunilal S.
    Semin Thromb Hemost; 2019 Mar 03; 45(2):187-195. PubMed ID: 30566971
    [Abstract] [Full Text] [Related]

  • 19. Long-term clinical outcomes in older patients with acute venous thromboembolism who have renal impairment.
    Messi M, Beneyto Afonso C, Stalder O, Méan M, Righini M, Rodondi N, Aujesky D.
    Thromb Res; 2022 Oct 03; 218():64-71. PubMed ID: 35994838
    [Abstract] [Full Text] [Related]

  • 20. The association of recurrence and bleeding events with mortality after venous thromboembolism: From the COMMAND VTE Registry.
    Yamashita Y, Yoshikawa Y, Morimoto T, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Tada T, Chen PM, Murata K, Tsuyuki Y, Saga S, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Shiomi H, Kato T, Makiyama T, Ono K, Kimura T, COMMAND VTE Registry Investigators.
    Int J Cardiol; 2019 Oct 01; 292():198-204. PubMed ID: 31239211
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.